Abstract
Brain networks play a crucial role in the diagnosis of brain disorders by enabling the identification of abnormal patterns and connections in brain activities. Previous studies exploit the Pearson’s correlation coefficient to construct functional brain networks from fMRI data and use graph learning to diagnose brain diseases. However, correlation-based brain networks are overly dense (often fully connected), which obscures meaningful connections and complicates subsequent analyses. This dense connectivity poses substantial performance challenges to traditional graph transformers, which are primarily designed for sparse graphs. Consequently, this results in a notable reduction in diagnostic accuracy. To address this challenging issue, we propose a multifunctional brain graph transformer model for brain disorders diagnosis, namely BrainGT, which is capable of constructing multifunctional brain networks rather than a dense brain network from fMRI data. It utilizes the fusion of self-attention and cross-attention mechanisms to learn important features within and across multiple functional brain networks. Classification (diagnosis) experiments conducted on three real fMRI datasets (i.e., ADNI, PPMI, and ABIDE) demonstrate the superiority of the proposed BrainGT over state-of-the-art methods.
Impact Statement The proposed BrainGT model represents a substantial advancement in computational neuroscience, offering a promising tool for more accurate and efficient diagnosis of brain disorders. By constructing multifunctional brain networks from fMRI data, BrainGT overcomes the limitations of traditional graph transformers and correlation-based brain networks. This innovation has profound implications across social, economic, and technological dimensions. Socially, BrainGT can enhance the quality of life for individuals with brain disorders by enabling more accurate diagnoses, leading to more effective treatments and better patient outcomes. Economically, BrainGT has the potential to reduce healthcare costs by streamlining the diagnostic process and potentially reducing the need for more expensive or invasive procedures. Technologically, BrainGT pushes the boundaries of AI and neuroscience, opening new avenues for research and development. It demonstrates the potential of AI to handle complex and dense data structures, with applications that could extend to other fields.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
(e-mail: ahsan{at}mail.dlut.edu.cn; shagufta{at}mail.dlut.edu.cn).
(e-mail: zhangdongyu{at}dlut.edu.cn)
(e-mail: shuo.yu{at}ieee.org)
(e-mail: zhoujingjing{at}zjgsu.edu.cn)
(e-mail: f.xia{at}ieee.org, xcheng430{at}outlook.com))
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.